Session 23: Medicine: Evidence-Based Research: Plenary Session
Moderator: George T. Rodeheaver, PhD
Abstract: This session will present new evidence-based data from recently performed clinical trails to be chosen before the meeting. Dr. Rodeheaver will moderate the session and provide introductions where appropriate.
(23.1) The SIDESTEP study of diabetic foot infections: a multicenter, double-blinded, randomized, controlled trial of ertapenem versus piperacillin/tazobactam
(23.2) Bioactive small intestinal submucosa stimulates VEGF secretion
(23.3) MIST ultrasound: the results of a multi-center, randomized, double-blind, sham-controlled trial of the healing of diabetic foot ulcers
(23.4) Adjunctive bioengineered bilayered cell therapy* with revascularization improves wound healing and limb salvage in critical limb ischemia
(23.5) A pilot clinical study for the treatment of diabetic foot ulcers with an injectable bioactive co-polymer
Session 32: Oral Abstracts (Session 1 of 5)
Moderator: Patricia M. Mertz, BA
(32.1) A noninvasive electric magnetic field device accelerates skin keratinocyte migration
(32.2) Can platelet rich plasma gels enhance epithelization of deep partial-thickness wounds?
(32.3) Effects of low-frequency ultrasound applied in vitro to highly antibiotic-resistant acinetobacter isolates recovered from soldiers returning from Iraq
(32.4) Proteolytic differences between acute and chronic wounds: the role of serine proteases and their inhibitors
(32.5) HSP70 is proinflammatory in vivo: implications for chronic wound healing
(32.6) The effect of a topical oxygen emulsion on collagen deposition and angiogenesis in partial-thickness wounds
Session 33: Oral Abstracts (Session 2 of 5)
Moderator: John M. MacDonald, MD, FACS
(33.1) Pressure ulcer prevention through a caregiver education website
(33.2) Burden of pressure ulcer care
(33.3) Vacuum-assisted closure treatment of sternal wound infections following cardiac surgery
(33.4) Effectiveness of a topical formulation containing metronidazole for wound odor and exudate control
(33.5) PVP-iodine liposome hydrogel—a novel concept in wound therapy enhances epithelialization and reduces loss of mesh grafts
Session 34: Oral Abstracts (Session 3 of 5)
Moderator: Susan Dieter, RN, MS, CWCN, CWS
(34.1) Unanticipated benefit of ultrasonic MIST™ therapy on chronic wound pain
(34.2) Management of periwound skin in venous leg ulcers
(34.3) The use of low-frequency ultrasound in the treatment of chronic foot and leg ulcerations: a 51 patient retrospective analysis
(34.4) A randomized, open-label, multicenter study to compare the safety and efficacy of bi-layered cell therapy versus standard therapy in the treatment of diabetic foot ulcers
(34.5) Wound mapping* with high-resolution ultrasound provides objective, accurate, and reproducible wound measurements for clinical trials
Session 35: Oral Abstracts (Session 4 of 5)
Moderator: Cindy Felty, RN, CNP, CWS
(35.1) Master of science in wound healing: a 5-year review
(35.2) The development of public policy for improved client outcomes in wound care
(35.3) Increased revenue capture through the implementation of a nurse practitioner as provider in an outpatient wound care center
(35.4) Benchmarking wound healing outcomes in an outpatient clinic
(35.5) Evaluating health-related quality of life with lymphedema: a review of the literature
Session 36: Oral Abstracts (Session 5 of 5)
Moderator: David Keast, MSc, MD, CCFP, FCFP
(36.1) The use of an electronic measuring device to measure wound area in clinical trials
(36.2) Maggot therapy and infection control in venous ulcers: a comparative study
(36.3) A randomized, multicenter, clinical trial of a biocellulose wound dressing (BWD) for the treatment of chronic venous ulcers
(36.4) Immune response to an extracellular matrix tissue graft used to treat chronic venous ulcers
(36.5) A novel fetal bovine dermal matrix scaffold is rapidly incorporated into animal and human wounds resulting in wound bed stimulation
